Article Text

Download PDFPDF

Selective proteasome inhibitors may provide a novel therapeutic approach to Mycobacterium tuberculosis
Free
  1. S Mahendran
  1. Correspondence to S Mahendran, SpR Respiratory Medicine, East Sussex Hospitals, UK; drsivamahendran{at}gmail.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Proteasomes are large protein complexes that are structurally conserved across eukaryote cells including mycobacteria. They are needed to degrade unneeded or damaged proteins and, as such, have a vital role in cellular homeostasis. The cytotoxicity of proteasome inhibitors has been demonstrated by bortezomib (Velcade), which was the first therapeutic proteasome …

View Full Text